Literature DB >> 26212684

Developmental and behavioral consequences of prenatal methamphetamine exposure: A review of the Infant Development, Environment, and Lifestyle (IDEAL) study.

Lynne M Smith1, Sabrina Diaz2, Linda L LaGasse3, Trecia Wouldes4, Chris Derauf5, Elana Newman6, Amelia Arria7, Marilyn A Huestis8, William Haning5, Arthur Strauss9, Sheri Della Grotta3, Lynne M Dansereau3, Charles Neal4, Barry M Lester3.   

Abstract

This study reviews the findings from the Infant Development, Environment, and Lifestyle (IDEAL) study, a multisite, longitudinal, prospective study designed to determine maternal outcome and child growth and developmental findings following prenatal methamphetamine exposure from birth up to age 7.5 years. These findings are presented in the context of the home environment and caregiver characteristics to determine how the drug and the environment interact to affect the outcome of these children. No neonatal abstinence syndrome requiring pharmacologic intervention was observed but heavy drug exposure was associated with increased stress responses in the neonatal period. Poorer inhibitory control was also observed in heavy methamphetamine exposed children placing them at high risk for impaired executive function. Independent of methamphetamine exposure, children with more responsive home environments to developmental and emotional needs demonstrated lower risks for internalizing and externalizing behavior.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Longitudinal; Methamphetamine; Neurodevelopment; Prenatal exposure

Mesh:

Substances:

Year:  2015        PMID: 26212684      PMCID: PMC4668928          DOI: 10.1016/j.ntt.2015.07.006

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  62 in total

1.  Exposure to methamphetamine during first and second half of prenatal period and its consequences on cognition after long-term application in adulthood.

Authors:  I Hrebíčková; M Malinová-Ševčíková; E Macúchová; K Nohejlová; R Šlamberová
Journal:  Physiol Res       Date:  2014       Impact factor: 1.881

2.  The Brief Symptom Inventory: an introductory report.

Authors:  L R Derogatis; N Melisaratos
Journal:  Psychol Med       Date:  1983-08       Impact factor: 7.723

3.  Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome.

Authors:  Sandra W Jacobson; Lisa M Chiodo; Robert J Sokol; Joseph L Jacobson
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

4.  The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.

Authors:  Barry M Lester; Edward Z Tronick; Linda LaGasse; Ronald Seifer; Charles R Bauer; Seetha Shankaran; Henrietta S Bada; Linda L Wright; Vincent L Smeriglio; Jing Lu; Loretta P Finnegan; Penelope L Maza
Journal:  Pediatrics       Date:  2002-12       Impact factor: 7.124

5.  The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes.

Authors:  Charles R Bauer; Seetha Shankaran; Henrietta S Bada; Barry Lester; Linda L Wright; Heidi Krause-Steinrauf; Vincent L Smeriglio; Loretta P Finnegan; Penelope L Maza; Joel Verter
Journal:  Am J Obstet Gynecol       Date:  2002-03       Impact factor: 8.661

6.  Association between patterns of maternal substance use and infant birth weight, length, and head circumference.

Authors:  Seetha Shankaran; Abhik Das; Charles R Bauer; Henrietta S Bada; Barry Lester; Linda L Wright; Vincent Smeriglio
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

7.  Long-term effects of neonatal methamphetamine exposure in rats on spatial learning in the Barnes maze and on cliff avoidance, corticosterone release, and neurotoxicity in adulthood.

Authors:  Michael T Williams; Tracy L Blankenmeyer; Tori L Schaefer; Carrie A Brown; Gary A Gudelsky; Charles V Vorhees
Journal:  Brain Res Dev Brain Res       Date:  2003-12-30

8.  Methamphetamine exposure during pregnancy at pharmacological doses produces neurodevelopmental and behavioural effects in rat offspring.

Authors:  Kate McDonnell-Dowling; Michelle Donlon; John P Kelly
Journal:  Int J Dev Neurosci       Date:  2014-03-22       Impact factor: 2.457

9.  Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment.

Authors:  Beau Abar; Linda L LaGasse; Trecia Wouldes; Chris Derauf; Elana Newman; Rizwan Shah; Lynne M Smith; Amelia M Arria; Marilyn A Huestis; Sheri DellaGrotta; Lynne M Dansereau; Tara Wilcox; Charles R Neal; Barry M Lester
Journal:  Prev Sci       Date:  2014-10

10.  Amphetamine addiction and pregnancy. III. One year follow-up of the children. Psychosocial and pediatric aspects.

Authors:  L Billing; M Eriksson; G Larsson; R Zetterström
Journal:  Acta Paediatr Scand       Date:  1980-09
View more
  13 in total

1.  Effects of Neonatal Methamphetamine and Stress on Brain Monoamines and Corticosterone in Preweanling Rats.

Authors:  Sarah A Jablonski; Devon L Graham; Charles V Vorhees; Michael T Williams
Journal:  Neurotox Res       Date:  2016-11-05       Impact factor: 3.911

2.  Developmental Exposure to Psychostimulant Primes Activity-dependent Gene Induction in Frontal Cortex.

Authors:  Yizhou Ye; Qing Liu; Wenyu Zhang; Surjeet Mastwal; Kuan Hong Wang
Journal:  Dev Neurobiol       Date:  2018-12-19       Impact factor: 3.964

Review 3.  Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newborn.

Authors:  Deepika Sankaran; Satyan Lakshminrusimha; Veena Manja
Journal:  J Perinatol       Date:  2021-11-16       Impact factor: 2.521

Review 4.  Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.

Authors:  Martha L Velez; Chloe J Jordan; Lauren M Jansson
Journal:  Neurotoxicol Teratol       Date:  2021-08-19       Impact factor: 3.763

Review 5.  [Methamphetamine : Epidemiology, clinical importance and sequelae of abuse].

Authors:  N Arnaud; R Thomasius
Journal:  Nervenarzt       Date:  2017-09       Impact factor: 1.214

6.  Motor delays in MDMA (ecstasy) exposed infants persist to 2 years.

Authors:  Lynn T Singer; Derek G Moore; Meeyoung O Min; Julia Goodwin; John J D Turner; Sarah Fulton; Andrew C Parrott
Journal:  Neurotoxicol Teratol       Date:  2016-01-21       Impact factor: 3.763

Review 7.  Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation.

Authors:  Asher Ornoy
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

Review 8.  The Effects of Drugs used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Pregnancy Outcome and Breast-feeding: A Critical Review.

Authors:  Asher Ornoy; Gideon Koren
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

9.  Sex-Specific Alterations of White Matter Developmental Trajectories in Infants With Prenatal Exposure to Methamphetamine and Tobacco.

Authors:  Linda Chang; Kenichi Oishi; Jon Skranes; Steven Buchthal; Eric Cunningham; Robyn Yamakawa; Sara Hayama; Caroline S Jiang; Daniel Alicata; Antonette Hernandez; Christine Cloak; Tricia Wright; Thomas Ernst
Journal:  JAMA Psychiatry       Date:  2016-12-01       Impact factor: 21.596

Review 10.  An environmental scan of impacts and interventions for women with methamphetamine use in pregnancy and their children.

Authors:  Melissa Ackerman; Claudia Madampage; Lynette J Epp; Kali Gartner; Alexandra King
Journal:  Int J Gynaecol Obstet       Date:  2021-08-23       Impact factor: 4.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.